LEXINGTON, Mass.--(BUSINESS WIRE)--CoNCERT Pharmaceuticals, Inc., a company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced it has appointed Justine E. Koenigsberg Senior Director, Corporate Communications and Investor Relations. In this new position, she will be responsible for developing, implementing and managing CoNCERT’s external communications strategy including its investor relations efforts. She will report to CoNCERT’s Chief Operating Officer, Nancy Stuart.
